`
`Description
`
`Abbreviation
`
`Paragraphs
`Cited
`
`EXPERT DECLARATION OF DR. KRISHNA V. KOMANDURI (EX. 2080)
`
`LIST OF EXHIBITS CITED
`
`
`1002
`
`1010
`
`1041
`
`1075
`
`1101
`
`2003
`
`2004
`
`PCT Published Application No. WO
`01/51049 A1, “O-Methylated
`Rapamycin Derivatives For Alleviation
`And Inhibition Of Lymphoproliferative
`Disorders,” to Wasik et al.
`Declaration of Allan J. Pantuck, M.D. in
`Support of Petition for Inter Partes
`Review of U.S. Patent No. 8,410,131
`Perez-Atayde, A.R. et al., “Spectrum Of
`Tumor Angiogenesis In The Bone
`Marrow Of Children With Acute
`Lymphoblastic Leukemia,” Am. J.
`Pathol. 150(3):815-821 (1997)
`Majewski, M. et al., “The
`Immunosuppresive Macrolide RAD
`Inhibits Growth Of Human Epstein-Barr
`Virus Transformed B Lymphocytes In
`Vitro And In Vivo: A Potential
`Approach To Prevention And Treatment
`Of Postrransplant Lymphoproliferative
`Disorders,” Proc. Natl. Acad. Sci.
`97(8):4285-4290 (2000)
`Motzer, R.J. & Vogelzang, N.J.,
`“Chemotherapy For Renal Cell
`Carcinoma,” Principles And Practice Of
`Genitourinary Oncology, pages 885-896
`(Raghavan, D. et al. eds., 1997)
`Laughlin, E.H., Coming To Terms With
`Cancer: A Glossary Of Cancer-Related
`Terms, pages 4, 126, 140, 173-174, 188-
`190 (2002)
`Altman, R. & Sarg, M.J., The Cancer
`Dictionary, 51-52, 278 (1992)
`
`
`
`1
`
`Wasik
`
`
`Passim
`
`Pantuck Decl.
`
`16, 20, 23
`
`Perez-Atayde
`
`34
`
`Majewski
`
`48, 53
`
`Motzer 1997
`
`10
`
`Laughlin
`
`Altman
`
`34, 35
`
`35
`
`NOVARTIS EXHIBIT 2110
`Breckenridge v. Novartis, IPR 2017-01592
`Page 1 of 3
`
`
`
`2005
`
`2007
`
`2028
`
`Sutcliffe, S.B. & Gospodarowicz, M.K.,
`Chapter 25, “Primary Extranodal
`Lymphomas,” The Lymphomas
`(Canellos, G.P. et al. eds., 1998)
`2006 Molina, A. & Penzer, R.D., Chapter 30,
`“Non-Hodgkin’s Lymphoma,” Cancer
`Management: A Multidisciplinary
`Approach: Medical, Surgical, &
`Radiation Oncologly, 4th Edition
`(Pazdur, R., et al. eds., 2000)
`Sutcliffe, S.B, & Godspodarowicz,
`M.K., “Clinical Features And
`Management Of Localized Extranodal
`Lymphomas,” Haematological
`Oncology, Volume 2 pages 198-222
`(Keating, A. et al. eds., 1992)
`2027 March 13, 2018 Deposition Testimony
`of Dr. Allan J. Pantuck
`Truong, L., et al., “The Diagnostic And
`Therapeutic Roles of Fine-Needle
`Aspiration,” Am. J. Clin. Pathol.
`115:18-31 (2001)
`2030 Abbas, Z, et al., “Renal Lymphoma: An
`Unusual Cause Of Extrahepatic Biliary
`Obstruction,” Postgraduate Med. J.
`617-618 (1996)
`Curriculum of Dr. Krishna V.
`Komanduri
`Robbins, S.L., et al., Chapter 15,
`“Diseases Of White Cells, Lymph
`Nodes, And Spleen,” Pathologic Basis
`Of Disease, 3rd Edition, pages 653-704
`(1984)
`Buzaid, A. & Cadman, E., Chapter 52:
`“Pharmacology Of Antineoplastic
`Agents And Mechanisms Of Multidrug
`Resistance,” Hematology Basic
`Principles And Practice (Hoffman, R. et
`al., eds., 1991)
`
`2081
`
`2095
`
`2096
`
`
`
`2
`
`Sutcliffe 1998
`
`Pazdur
`
`36, 39, 46, 48,
`50
`
`10, 37, 48
`
`Sutcliffe 1992
`
`37, 39, 48, 50
`
`Pantuck Tr.
`
`Truong
`
`Abbas
`
`Komanduri
`CV
`Robbins
`
`Buzzaid
`
`22
`
`10, 38
`
`38, 48
`
`13, 21
`
`37
`
`35, 37
`
`NOVARTIS EXHIBIT 2110
`Breckenridge v. Novartis, IPR 2017-01592
`Page 2 of 3
`
`
`
`2098
`
`Molldrem, J.J., et al., “Overexpressed
`Differentiation Antigens As Targets Of
`Graft-Versus-Leukemia Reactions,”
`Curr. Opin. Hematol. 9:503-508 (2002)
`
`
`Molldrem
`
`54
`
`
`
`3
`
`NOVARTIS EXHIBIT 2110
`Breckenridge v. Novartis, IPR 2017-01592
`Page 3 of 3
`
`